Task: Answer the multiple-choice question.
Question: Which compound exhibits a 3.155% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. O=C(c1ccc([N+](=O)[O-])cc1)n1nc(-c2ccccc2)nc1NCc1ccccc1
b. CN(C(=O)C1CCCO1)c1nnc(-c2ccccn2)s1
Answer: b. CN(C(=O)C1CCCO1)c1nnc(-c2ccccn2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C(=O)C1CCCO1)c1nnc(-c2ccccn2)s1
CN(C(=O)C1CCCO1)c1nnc(-c2ccccn2)s1
N-methyl-N-(5-pyridin-2-yl-1,3,4-thiadiazol-2-yl)oxolane-2-carboxamide